We at ROPHIBIO
aim to utilize our expertise and technology in protein/antibody therapy, gene/cell therapy,
and stem cell therapy to develop innovative biopharmaceuticals.
Advanced Biopharmaceutical Technologies for Innovative New Drug Development
ROPHIBIO’s biotherapeutics are designed to selectively target cancer cells and harmful substrates within the human body.
With the development of patient-personalized therapies via gene profiling, we seek to maximize therapeutic effects while reducing adverse side effects.
We at ROPHIBIO place our efforts into developing new drugs with the desire to instill
a new hope into patients with incurable disease.